Work

Biologics for Severe Asthma: Treatment-Specific Effects Are Important in Choosing a Specific Agent

Year: 2019

Type: article

Source: The Journal of Allergy and Clinical Immunology In Practice

DOI: 10.1016/j.jaip.2019.03.008

Authors: James G. Krings, Mary Clare McGregor, Leonard B. Bacharier, Mario Castro

Institutions: Washington University in St. Louis, St. Louis Children's Hospital

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, American Lung Association, AstraZeneca, Novartis, Sanofi, Cephalon, Patient-Centered Outcomes Research Institute, Teva Pharmaceutical Industries, Chiesi Farmaceutici, Chiesi España, MedImmune, National Institutes of Health

OpenAlex ID: W2943862298

FWCI: 6.837

Cites: 135

Cited by: 67

Related to: 10